Gliclazide 80mg Tablet
Reviewed educational reference: what Gliclazide is used for, how it works, its side effects and safety advice, plus the Indian brands that contain it.
- Molecule
- Gliclazide
- Strength
- 80mg
- Dosage form
- Tablet
- Drug class
- Sulfonylurea
Related products
No reviewed products are currently published for this generic.
Gliclazide 80mg Tablet contains Gliclazide, which belongs to the sulfonylurea class of oral antidiabetic medications. It is primarily indicated for the management of type 2 diabetes mellitus in adults when dietary measures, physical exercise, and weight reduction alone are insufficient to control blood glucose levels. By stimulating the release of insulin from the pancreatic beta cells, Gliclazide 80mg Tablet helps lower blood sugar levels effectively.
At a glance
Gliclazide 80mg Tablet contains 80mg of Gliclazide.
It stimulates the pancreas to produce more insulin to lower blood sugar.
It is used for the management of type 2 diabetes mellitus.
Uses of Gliclazide
- Management of type 2 diabetes mellitus
- Control of hyperglycemia in adults
- Adjunct to diet and exercise for glycemic control
- Reduction of microvascular complications in diabetes
- Management of patients unresponsive to lifestyle modifications
- Long-term maintenance of blood glucose stability
Benefits of Gliclazide
Improved Glycemic Control
The primary benefit of Gliclazide 80mg Tablet is its ability to lower fasting and postprandial blood glucose levels. By enhancing the sensitivity of pancreatic beta cells to glucose, it ensures a more physiological release of insulin, which is essential for maintaining metabolic balance in patients with type 2 diabetes.
Cardiovascular and Microvascular Protection
Beyond glucose lowering, Gliclazide is associated with potential benefits in reducing the risk of long-term diabetic complications. Clinical evidence suggests that consistent use of Gliclazide 80mg Tablet can help protect against microvascular damage, such as retinopathy and nephropathy, by maintaining stable blood sugar levels over extended periods.
Side effects of Gliclazide
The most common side effect associated with Gliclazide 80mg Tablet is hypoglycemia, which occurs when blood sugar levels drop too low. Symptoms include dizziness, shakiness, sweating, confusion, and hunger. Other gastrointestinal disturbances such as nausea, vomiting, diarrhea, or abdominal pain may occur, particularly when starting the medication. Skin reactions like rashes or itching are rare but possible. In some cases, changes in liver function tests or blood counts, such as anemia or thrombocytopenia, have been reported. If you experience severe symptoms like persistent jaundice, dark urine, or unexplained bruising, seek medical attention immediately. Most side effects are manageable by adjusting the timing of doses or ensuring consistent food intake.
| Side effect | How common | How severe | What to do |
|---|---|---|---|
| Hypoglycemia | Common | Moderate | Carry fast-acting sugar sources. |
| Gastrointestinal upset | Common | Mild | Take with food. |
| Skin rash | Uncommon | Mild | Discontinue and consult a doctor. |
How to manage side effects
Hypoglycemia
- 1. Recognize symptoms like sweating and tremors.
- 2. Consume 15g of fast-acting carbohydrates.
- 3. Recheck blood glucose after 15 minutes.
- 4. Seek medical help if symptoms persist.
Gastrointestinal upset
- 1. Ensure the tablet is taken during a meal.
- 2. Avoid spicy or heavy foods.
- 3. Consult a doctor if symptoms are persistent.
Skin rash
- 1. Stop the medication.
- 2. Observe for signs of allergic reaction.
- 3. Seek medical advice for alternative therapy.
How to use Gliclazide
- Take Gliclazide 80mg Tablet orally with a glass of water, preferably during breakfast or your first main meal of the day.
- Swallow the tablet whole; do not crush, chew, or break it unless specified by your doctor.
- Maintain a consistent daily schedule for taking your medication to ensure stable blood glucose levels.
- Never skip a meal after taking your dose, as this significantly increases the risk of hypoglycemia.
- Follow the specific dosage prescribed by your healthcare provider based on your blood sugar readings.
Special population advice
Kidney impairment
- Use with caution in mild to moderate impairment.
- Monitor blood glucose levels frequently.
- Avoid in severe renal failure.
Liver impairment
- Monitor liver enzymes regularly.
- Dose reduction may be necessary.
- Avoid in severe hepatic failure.
Children
- Not indicated for pediatric use.
- Safety and efficacy not established.
Elderly
- Start with the lowest effective dose.
- Monitor closely for signs of hypoglycemia.
- Ensure adequate nutritional intake.
How Gliclazide works
Gliclazide works by binding to specific receptors on the surface of pancreatic beta cells. This action closes ATP-sensitive potassium channels, leading to cell depolarization and the subsequent opening of calcium channels. The influx of calcium triggers the release of stored insulin, which helps the body utilize glucose more effectively.
What if you miss or exceed a dose?
If you miss a dose
If you miss a dose of Gliclazide 80mg Tablet, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular routine. Do not take a double dose to make up for a forgotten one, as this can lead to dangerously low blood sugar levels.
In case of overdose
An overdose of Gliclazide 80mg Tablet can lead to severe and potentially life-threatening hypoglycemia. Symptoms include extreme weakness, blurred vision, tremors, sweating, confusion, and loss of consciousness. If you suspect an overdose, seek emergency medical help immediately. You may require intravenous glucose administration or hospitalization for monitoring.
Treatment is supportive and focused on correcting hypoglycemia.
- Immediate Action
- Administer oral glucose if the patient is conscious.
- Hospitalization
- Intravenous dextrose infusion is required for severe cases.
- Monitoring
- Continuous blood glucose monitoring for at least 24-48 hours.
- Supportive Care
- Maintain airway and manage symptoms of autonomic nervous system activation.
Safety and precautions
When to avoid Gliclazide
- Type 1 diabetes
Not effective as these patients require insulin.
- Diabetic ketoacidosis
Requires immediate insulin therapy.
- Severe renal impairment
Risk of prolonged hypoglycemic effect.
- Severe hepatic impairment
Metabolism may be altered.
- G6PD deficiency
Risk of hemolytic anemia.
- Elderly patients
Increased susceptibility to hypoglycemia.
Safety at a glance
Alcohol can potentiate the hypoglycemic effect of Gliclazide and mask warning signs.
Generally not recommended; insulin is preferred for glycemic control during pregnancy.
Consult your doctor, as the drug may pass into breast milk.
Hypoglycemia can impair your ability to drive; ensure your blood sugar is stable before operating machinery.
Use with caution in patients with renal impairment; dose adjustment may be required.
Monitor liver function closely in patients with hepatic impairment.
Do not use if you have a known allergy to sulfonylureas or sulfonamides.
Not recommended for use in children or adolescents under 18 years of age.
Elderly patients are at higher risk of hypoglycemia; start with a lower dose.
Interactions
With other medicines
NSAIDs
ModerateChanges the medicine’s effect
What can happen: Increased risk of hypoglycemia
What to do: Monitor blood glucose levels more frequently.
Beta-blockers
ModerateChanges the medicine’s effect
What can happen: Masking of hypoglycemia symptoms
What to do: Use with caution and monitor glucose levels.
Corticosteroids
ModerateChanges the medicine’s effect
What can happen: Reduced glycemic control
What to do: Adjust dose of Gliclazide as needed.
With food and drink
- AlcoholMajor
Increases risk of severe hypoglycemia and masks symptoms.
- High-sugar foodsModerate
Can cause rapid blood glucose spikes and counteract the therapeutic effect of the medication.
If you have another condition
- Renal failure
Requires dose reduction and careful monitoring.
- Hepatic disease
May lead to accumulation of the drug.
Effect on laboratory tests
- Blood glucose
Decreased levels
Expected therapeutic effect; monitor to avoid hypoglycemia.
- HbA1c
Decreased levels
Indicates improved long-term glycemic control.
Quick tips
- Always carry a source of fast-acting sugar, such as glucose tablets or fruit juice, to treat sudden hypoglycemic episodes.
- Inform your doctor if you are planning to change your diet or exercise routine, as this may require a dose adjustment.
- Regularly monitor your blood glucose levels at home as advised by your healthcare provider.
- Avoid excessive alcohol consumption, as it can mask the symptoms of hypoglycemia and interfere with blood sugar control.
- Wear a medical identification tag stating that you have diabetes and are taking medication.
Counselling points
- Hypoglycemia awarenessImportant
Learn to recognize symptoms like sweating, tremors, and confusion.
- Dietary consistencyImportant
Eat meals at regular intervals to prevent low blood sugar.
- Alcohol intakeGood to know
Limit alcohol as it can cause unpredictable blood sugar drops.
- Missed dosesGood to know
Do not double the dose if you miss one.
Monitoring during treatment
Before starting
- Fasting blood glucose
- HbA1c
- Renal function tests
- Liver function tests
During treatment
- every 3 months: HbA1c and fasting blood glucose monitoring
What is being watched
- Blood glucose
- HbA1c
- Weight
- Renal function
Pharmacokinetics
- Absorption
- Rapid and complete from the gastrointestinal tract.
- Bioavailability
- High, nearly 100%.
- Protein binding
- Highly bound to plasma proteins (approx 95%).
- Volume of distribution
- Approximately 10-15 liters.
- Half-life
- 10 to 12 hours.
- Metabolism
- Extensively metabolized in the liver.
- Excretion
- Primarily excreted in urine as metabolites.
- Onset / duration
- Onset within 1 hour; duration up to 24 hours.
Fact box
- Chemical class
- Sulfonylurea derivative
- Habit forming
- No
- Therapeutic class
- Antidiabetic agent
- Action class
- Insulin secretagogue
- Storage
- Store at room temperature below 30°C in a dry place, away from direct sunlight and moisture. Keep out of reach of children.
- ATC code
- A10BB09
- Pregnancy category
- C
More information
Clinical Rationale for Gliclazide
Clinicians often select Gliclazide as a first-line or early second-line therapy for type 2 diabetes due to its favorable safety profile compared to other older sulfonylureas. Unlike some agents in its class, Gliclazide is known for a lower risk of severe, prolonged hypoglycemia, which is a critical factor when treating elderly patients or those with irregular lifestyles. Its mechanism of action is highly specific to the pancreatic beta cells, which helps in restoring the early-phase insulin response that is typically lost in diabetic patients. This physiological approach makes it a reliable choice for achieving glycemic targets while minimizing the risk of weight gain, which is a common concern with many antidiabetic medications. Furthermore, its once-daily or twice-daily dosing regimen improves patient adherence, which is essential for long-term success in chronic disease management.
Comparison with Alternatives
When comparing Gliclazide to other oral antidiabetic agents like metformin or DPP-4 inhibitors, the choice depends on the patient's specific metabolic profile. Metformin remains the gold standard for initial therapy due to its weight-neutral profile and lack of hypoglycemic risk. However, when metformin is contraindicated or insufficient, Gliclazide serves as a potent alternative. Compared to older sulfonylureas like glibenclamide, Gliclazide offers a more predictable pharmacokinetic profile and a reduced risk of nocturnal hypoglycemia. While newer classes like SGLT2 inhibitors or GLP-1 receptor agonists offer cardiovascular benefits, Gliclazide remains a cost-effective and highly accessible option for patients in resource-limited settings, providing robust glucose control when used appropriately within a comprehensive management plan.
Lifestyle and Dietary Considerations
Effective management of diabetes with Gliclazide 80mg Tablet requires a structured approach to lifestyle. Patients must understand that the medication is not a substitute for diet and exercise but rather a tool to enhance the body's response to these interventions. A diet rich in complex carbohydrates, fiber, and lean proteins is recommended to prevent rapid spikes in blood glucose. It is vital to avoid skipping meals, as the insulin-releasing effect of Gliclazide continues even if food is not consumed, leading to hypoglycemia. Regular physical activity is encouraged, but patients should be aware that intense exercise can also lower blood sugar levels, potentially necessitating a snack before or during the activity. Maintaining a food diary can help patients and clinicians identify patterns and adjust doses for optimal control.
What to Expect During Treatment
Upon starting Gliclazide 80mg Tablet, patients should expect a gradual improvement in their blood glucose levels over the first few weeks. It is normal for the doctor to start with a lower dose and titrate upwards based on weekly glucose monitoring results. During the initial phase, patients should be vigilant for signs of hypoglycemia, especially during the transition period as the body adjusts to the medication. Over the course of treatment, regular follow-ups are necessary to assess HbA1c levels, which provide a three-month average of glycemic control. Patients should not be discouraged if their dose needs adjustment, as diabetes is a progressive condition and the body's insulin requirements may change over time. Consistent communication with the healthcare team ensures that the treatment remains safe and effective throughout the course of therapy.
References
- Medicines.org.uk. Gliclazide 80mg Tablets, Summary of Product Characteristics.View sourceAccessed
- Patient.info. Gliclazide tablets BP 80mg.View sourceAccessed
- Bristol Laboratories Ltd. Gliclazide 80mg Tablets Patient Information Leaflet.View sourceAccessed
- Tripathi KD. Essentials of Medical Pharmacology. 8th ed. Jaypee Brothers Medical Publishers, 2019.Accessed
- Medicines.org.uk. Gliclazide Patient Information Leaflet.View sourceAccessed
Frequently asked questions about Gliclazide
Can I take Gliclazide 80mg Tablet on an empty stomach?
It is generally recommended to take Gliclazide 80mg Tablet with food to reduce the risk of stomach upset and hypoglycemia.
What should I do if I feel dizzy after taking the tablet?
Dizziness may be a sign of low blood sugar. Check your glucose level and consume a fast-acting sugar source if necessary.
How long does it take for Gliclazide 80mg Tablet to work?
The onset of action typically occurs within 30 to 60 minutes, but full glycemic control may take several days of consistent use.
Is Gliclazide 80mg Tablet safe for long-term use?
Yes, it is commonly prescribed for long-term management of type 2 diabetes under regular medical supervision.
Does Gliclazide 80mg Tablet cause weight gain?
Weight gain is a possible side effect of sulfonylureas, though it is often less pronounced with Gliclazide compared to other agents.
Most bought this month
1Crocin Advance 500 TabletGlaxoSmithKline Pharmaceuticals Ltd₹22.25
2Glycomet 500 TabletUSV Pvt Ltd₹18.80
3Mox 500 CapsuleSun Pharmaceutical Industries Ltd₹72.80
4Cetzine TabletGlaxoSmithKline Pharmaceuticals Ltd₹25.70
5Calpol 650 TabletGlaxoSmithKline Pharmaceuticals Ltd₹30.50
Ranked by how often readers opened a partner link in the last 30 days.
All medicines →